Sorry, you need to enable JavaScript to visit this website.

INSPRA® (eplerenone) Patient Counseling Information

17 PATIENT COUNSELING INFORMATION

Advise patients receiving INSPRA:

  • Not to use potassium supplements or salt substitutes containing potassium without consulting the prescribing physician [see Warnings and Precautions (5.1)].
  • To call their physician if they experience dizziness, diarrhea, vomiting, rapid or irregular heartbeat, lower extremity edema, or difficulty breathing [see Warnings and Precautions (5.1)].

This product's labeling may have been updated. For the most recent prescribing information, please visit www.pfizer.com.

What's New

No Current Announcements.

Contact Pfizer Medical

Search

Please enter your search term(s) for INSPRA®